BriaCell Publishes Clinical Findings in 2018 American Society of Clinical Oncology (ASCO) Meeting
BriaCell Therapeutics Corp. ("BriaCell"), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, announced today that it will publish its clinical findings in the American Society of Clinical Oncology (ASCO) Annual Meeting Proceedings. ASCO's Annual Meeting, taking place June 1-5, 2018 in Chicago, IL, represents the world's largest gathering of oncology physicians, biotechnology executives, researchers, and investment analysts to discuss breakthrough clinical research and therapeutics in the field.
View full press release